- Patent Title: Immunoassay for the determination of Fc-region modified antibodies
-
Application No.: US15988939Application Date: 2018-05-24
-
Publication No.: US11561229B2Publication Date: 2023-01-24
- Inventor: Kay-Gunnar Stubenrauch
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Priority: EP15197058 20151130
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/68 ; G01N33/558 ; G01N33/543

Abstract:
Herein is reported a method for the determination of the amount of a bivalent antibody in a serum or plasma sample obtained from a non-human experimental animal, whereby the antibody comprises one or more mutations in the Fc-region compared to the corresponding wild-type Fc-region that has a sequence of SEQ ID NO: 01, 02, or 03, wherein the method comprises the following steps a) immobilizing a non-antibody polypeptide to which more than one copy of the antigen of the antibody is covalently conjugated on a solid surface, b) incubating the immobilized antigen with the sample to form an immobilized antigen-antibody complex, c) incubating the immobilized antigen-antibody complex with the antigen conjugated to a detectable label to form an immobilized ternary complex, and d) determining the amount of the antibody by determining the amount of the detectable label in the immobilized ternary complex.
Public/Granted literature
- US20180364251A1 Immunoassay for the determination of Fc-region modified antibodies Public/Granted day:2018-12-20
Information query
IPC分类: